{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T21:32:35Z","timestamp":1789421555973,"version":"build-2803163510"},"reference-count":73,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001537","name":"University of Auckland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001537","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.autrev.2022.103209","type":"journal-article","created":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T21:44:22Z","timestamp":1665438262000},"page":"103209","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Cytokine imbalance in acute rheumatic fever and rheumatic heart disease: Mechanisms and therapeutic implications"],"prefix":"10.1016","volume":"21","author":[{"given":"Francis M.","family":"Middleton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reuben","family":"McGregor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel H.","family":"Webb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel J.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole J.","family":"Moreland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2022.103209_bb0005","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0140-6736(18)30999-1","article-title":"Acute rheumatic fever","volume":"392","author":"Karthikeyan","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2022.103209_bb0010","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2021-007038","article-title":"Preceding group a streptococcus skin and throat infections are individually associated with acute rheumatic fever: evidence from New Zealand","volume":"6","author":"Oliver","year":"2021","journal-title":"BMJ Glob Health"},{"key":"10.1016\/j.autrev.2022.103209_bb0015","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global burden of cardiovascular diseases and risk factors, 1990\u20132019: update from the GBD 2019 study","volume":"76","author":"Roth","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.autrev.2022.103209_bb0020","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/INF.0b013e3181fbd85b","article-title":"Acute rheumatic fever associated with household crowding in a developed country","volume":"30","author":"Jaine","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.autrev.2022.103209_bb0025","article-title":"Risk factors for group a streptococcal pharyngitis and skin infections: a case control study","volume":"26","author":"Bennett","year":"2022","journal-title":"Lancet Reg Health-Western Pacific"},{"key":"10.1016\/j.autrev.2022.103209_bb0030","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3201\/eid2701.191791","article-title":"Rising ethnic inequalities in acute rheumatic fever and rheumatic heart disease, New Zealand, 2000\u20132018","volume":"27","author":"Bennett","year":"2021","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.autrev.2022.103209_bb0035","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/S0002-9440(10)63415-3","article-title":"Rheumatic heart disease: proinflammatory cytokines play a role in the progression and maintenance of valvular lesions","volume":"165","author":"Guilherme","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2022.103209_bb0040","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1089\/jir.2011.0065","article-title":"Cytokines in autoimmunity: role in induction, regulation, and treatment","volume":"31","author":"Moudgil","year":"2011","journal-title":"J Interf Cytokine Res"},{"key":"10.1016\/j.autrev.2022.103209_bb0045","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1093\/intimm\/dxv063","article-title":"Therapeutic antibodies that target inflammatory cytokines in autoimmune diseases","volume":"28","author":"Lai","year":"2016","journal-title":"Int Immunol"},{"key":"10.1016\/j.autrev.2022.103209_bb0050","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1161\/01.CIR.103.3.401","article-title":"Intravenous immunoglobulin in acute rheumatic fever: a randomized controlled trial","volume":"103","author":"Voss","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.autrev.2022.103209_bb0055","doi-asserted-by":"crossref","first-page":"e120","DOI":"10.1097\/INF.0000000000002647","article-title":"The treatment of acute rheumatic fever: novel use of hydroxychloroquine","volume":"39","author":"Wilson","year":"2020","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.autrev.2022.103209_bb0060","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003176.pub3","article-title":"Anti-inflammatory treatment for carditis in acute rheumatic fever","author":"Cilliers","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.autrev.2022.103209_bb0065","first-page":"1","article-title":"Immune signature of acute pharyngitis in a Streptococcus pyogenes human challenge trial, nature","volume":"13","author":"Anderson","year":"2022","journal-title":"Communications"},{"key":"10.1016\/j.autrev.2022.103209_bb0070","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/s41423-018-0005-3","article-title":"Chemokine and chemotactic signals in dendritic cell migration","volume":"15","author":"Tiberio","year":"2018","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.autrev.2022.103209_bb0075","doi-asserted-by":"crossref","first-page":"E433","DOI":"10.1152\/ajpendo.00074.2003","article-title":"IL-6 enhances plasma IL-1ra, IL-10, and cortisol in humans","volume":"285","author":"Steensberg","year":"2003","journal-title":"Am J Physiol-Endocrinol Metab"},{"key":"10.1016\/j.autrev.2022.103209_bb0080","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/bjh.12616","article-title":"Advances in understanding the pathogenesis of autoimmune disorders: focus on chemokines and lymphocyte trafficking","volume":"164","author":"Comerford","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.autrev.2022.103209_bb0085","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.cyto.2014.09.011","article-title":"T cell subsets and their signature cytokines in autoimmune and inflammatory diseases","volume":"74","author":"Raphael","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.autrev.2022.103209_bb0090","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jaut.2008.04.017","article-title":"Role of Th1 and Th17 cells in organ-specific autoimmunity","volume":"31","author":"Dardalhon","year":"2008","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2022.103209_bb0095","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/s41584-019-0322-7","article-title":"Shared and distinct mechanisms of fibrosis","volume":"15","author":"Distler","year":"2019","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2022.103209_bb0100","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nri2094","article-title":"Cytokines in the pathogenesis of rheumatoid arthritis","volume":"7","author":"McInnes","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2022.103209_bb0105","first-page":"335","article-title":"Translating IL-6 biology into effective treatments, nature reviews","volume":"16","author":"Choy","year":"2020","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2022.103209_bb0110","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3109\/03009749509095185","article-title":"Plasma interleukin-7 (IL-7) and IL-8 concentrations in acute rheumatic fever and chronic rheumatic heart disease","volume":"24","author":"K\u00fct\u00fck\u00e7\u00fcler","year":"1995","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.autrev.2022.103209_bb0115","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1161\/CIRCULATIONAHA.118.033891","article-title":"Dysregulated IL-1\u03b2-GM-CSF axis in acute rheumatic fever that is limited by hydroxychloroquine","volume":"138","author":"Kim","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.autrev.2022.103209_bb0120","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s004310050545","article-title":"Cytokines in acute rheumatic fever","volume":"156","author":"Ye\u011fin","year":"1996","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.autrev.2022.103209_bb0125","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1017\/S1047951114001012","article-title":"Plasma adiponectin levels and relations with cytokines in children with acute rheumatic fever","volume":"25","author":"Ozgen","year":"2015","journal-title":"Cardiol Young"},{"key":"10.1016\/j.autrev.2022.103209_bb0130","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2174\/1389200024605082","article-title":"Neopterin as a marker for immune system activation","volume":"3","author":"Murr","year":"2002","journal-title":"Curr Drug Metab"},{"key":"10.1016\/j.autrev.2022.103209_bb0135","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1006\/clin.1995.1005","article-title":"Serum-soluble receptors for tumor necrosis factor-\u03b1 and interleukin-2, and neopterin in acute rheumatic fever","volume":"74","author":"Samsonov","year":"1995","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.autrev.2022.103209_bb0140","first-page":"652","article-title":"High neopterin levels in acute rheumatic fever","volume":"18","author":"Narin","year":"2000","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2022.103209_bb0145","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1006\/clin.1995.1140","article-title":"Lymphocyte subsets and plasma IL-1 \u03b1, IL-2, and TNF-\u03b1 concentrations in acute rheumatic fever and chronic rheumatic heart disease","volume":"77","author":"Narin","year":"1995","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.autrev.2022.103209_bb0150","first-page":"251","article-title":"Contribution of selected serum inflammatory mediators to the progression of chronic rheumatic valve disease, subsequent valve calcification and NYHA functional class","volume":"14","author":"Davutoglu","year":"2005","journal-title":"J Heart Valve Dis"},{"key":"10.1016\/j.autrev.2022.103209_bb0155","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1159\/000088104","article-title":"Balance between plasma levels of tumor necrosis factor-\u03b1 and interleukin-10 in rheumatic mitral stenosis","volume":"104","author":"Chen","year":"2005","journal-title":"Cardiology"},{"key":"10.1016\/j.autrev.2022.103209_bb0160","doi-asserted-by":"crossref","first-page":"78","DOI":"10.2310\/JIM.0000000000000023","article-title":"A shift in the balance of regulatory T and T helper 17 cells in rheumatic heart disease","volume":"62","author":"Bas","year":"2014","journal-title":"J Investig Med"},{"key":"10.1016\/j.autrev.2022.103209_bb0165","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000003562","article-title":"Serum levels of IL-17 and IL-23 in patients with rheumatic mitral stenosis","volume":"95","author":"Bilik","year":"2016","journal-title":"Medicine"},{"key":"10.1016\/j.autrev.2022.103209_bb0170","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ijcard.2019.04.063","article-title":"Circulating cytokines predict severity of rheumatic heart disease","volume":"289","author":"Soares","year":"2019","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.autrev.2022.103209_bb0175","first-page":"329","article-title":"Decreased cytokine plasma levels and changes in T-cell activation are associated with hemodynamic improvement and clinical outcomes after percutaneous mitral commissurotomy in patients with rheumatic mitral stenosis","volume":"7","author":"Silva","year":"2020","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.autrev.2022.103209_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2021.155711","article-title":"Systemic cytokines, chemokines and growth factors reveal specific and shared immunological characteristics in infectious cardiomyopathies","volume":"148","author":"Neves","year":"2021","journal-title":"Cytokine"},{"key":"10.1016\/j.autrev.2022.103209_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2020.155370","article-title":"Cytokine gene functional polymorphisms and phenotypic expression as predictors of evolution from latent to clinical rheumatic heart disease","volume":"138","author":"Tormin","year":"2021","journal-title":"Cytokine"},{"key":"10.1016\/j.autrev.2022.103209_bb0190","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.carpath.2015.07.006","article-title":"Changes in the expression of Th17 cell-associated cytokines in the development of rheumatic heart disease","volume":"24","author":"Wen","year":"2015","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.autrev.2022.103209_bb0195","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3346\/jkms.2008.23.1.41","article-title":"Overexpression of transforming growth factor-\u03b21 in the valvular fibrosis of chronic rheumatic heart disease","volume":"23","author":"Kim","year":"2008","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.autrev.2022.103209_bb0200","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1007\/s10753-013-9606-2","article-title":"CXCL9\/Mig mediates T cells recruitment to valvular tissue lesions of chronic rheumatic heart disease patients","volume":"36","author":"Fa\u00e9","year":"2013","journal-title":"Inflammation"},{"key":"10.1016\/j.autrev.2022.103209_bb0205","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1042\/CS20110340","article-title":"IL-6\/IL-6 receptor system and its role in physiological and pathological conditions","volume":"122","author":"Mihara","year":"2012","journal-title":"Clin Sci"},{"key":"10.1016\/j.autrev.2022.103209_bb0210","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.ejcb.2011.09.008","article-title":"Hepatic acute phase proteins\u2013regulation by IL-6-and IL-1-type cytokines involving STAT3 and its crosstalk with NF-\u03baB-dependent signaling","volume":"91","author":"Bode","year":"2012","journal-title":"Eur J Cell Biol"},{"key":"10.1016\/j.autrev.2022.103209_bb0215","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1084\/jem.20170580","article-title":"B cell\u2013derived IL-6 initiates spontaneous germinal center formation during systemic autoimmunity","volume":"214","author":"Arkatkar","year":"2017","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2022.103209_bb0220","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a028456","article-title":"Interleukin (IL-6) immunotherapy","volume":"10","author":"Tanaka","year":"2018","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.autrev.2022.103209_bb0225","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1182\/blood-2004-12-4602","article-title":"Humanized anti\u2013interleukin-6 receptor antibody treatment of multicentric Castleman disease","volume":"106","author":"Nishimoto","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2022.103209_bb0230","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1248\/bpb.31.1159","article-title":"Tocilizumab, a humanized anti-interleukin-6 receptor antibody, ameliorates joint swelling in established monkey collagen-induced arthritis","volume":"31","author":"Uchiyama","year":"2008","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.autrev.2022.103209_bb0235","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s00296-009-0953-0","article-title":"Anti-inflammatory mechanism of tocilizumab, a humanized anti-IL-6R antibody: effect on the expression of chemokine and adhesion molecule","volume":"30","author":"Suzuki","year":"2010","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.autrev.2022.103209_bb0240","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.cyto.2016.06.029","article-title":"Association study involving polymorphisms in IL-6, IL-1RA, and CTLA4 genes and rheumatic heart disease in New Zealand population of M\u0101ori and Pacific ancestry","volume":"85","author":"Azevedo","year":"2016","journal-title":"Cytokine"},{"key":"10.1016\/j.autrev.2022.103209_bb0245","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0203756","article-title":"Presence of increased inflammatory infiltrates accompanied by activated dendritic cells in the left atrium in rheumatic heart disease","volume":"13","author":"Shiba","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2022.103209_bb0250","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1212\/WNL.0000000000000317","article-title":"Efficacy of the anti\u2013IL-6 receptor antibody tocilizumab in neuromyelitis optica: a pilot study","volume":"82","author":"Araki","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2022.103209_bb0255","series-title":"Book A new era for the treatment of inflammatory autoimmune diseases by interleukin-6 blockade strategy","first-page":"88","article-title":"A new era for the treatment of inflammatory autoimmune diseases by interleukin-6 blockade strategy","author":"Tanaka","year":"2014"},{"key":"10.1016\/j.autrev.2022.103209_bb0260","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/nri802","article-title":"Development of anti-TNF therapy for rheumatoid arthritis","volume":"2","author":"Feldmann","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2022.103209_bb0265","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/S0140-6736(94)90628-9","article-title":"Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor \u03b1 (cA2) versus placebo in rheumatoid arthritis","volume":"344","author":"Elliott","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2022.103209_bb0270","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.4049\/jimmunol.163.3.1521","article-title":"Regulation of cytokines, cytokine inhibitors, and acute-phase proteins following anti-TNF-\u03b1 therapy in rheumatoid arthritis","volume":"163","author":"Charles","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2022.103209_bb0275","first-page":"38","article-title":"Reduction of chemokine levels and leukocyte traffic to joints by tumor necrosis factor \u03b1 blockade in patients with rheumatoid arthritis, Arthritis & Rheumatism: official journal of the American college of","volume":"43","author":"Taylor","year":"2000","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2022.103209_bb0280","first-page":"1","article-title":"Angiogenesis in rheumatoid arthritis","volume":"4","author":"Paleolog","year":"2002","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2022.103209_bb0285","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nrrheum.2015.169","article-title":"TNF biology, pathogenic mechanisms and emerging therapeutic strategies","volume":"12","author":"Kalliolias","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2022.103209_bb0290","series-title":"COVID-19: Multisystem inflammatory syndrome in children (MIS-C) management and outcome, Up to Date","author":"Son","year":"2021"},{"key":"10.1016\/j.autrev.2022.103209_bb0295","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.yjmcc.2010.10.033","article-title":"Transforming growth factor (TGF)-\u03b2 signaling in cardiac remodeling","volume":"51","author":"Dobaczewski","year":"2011","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.autrev.2022.103209_bb0300","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1161\/CIRCRESAHA.110.217737","article-title":"Potential therapeutic targets for cardiac fibrosis: TGF\u03b2, angiotensin, endothelin, CCN2, and PDGF, partners in fibroblast activation","volume":"106","author":"Leask","year":"2010","journal-title":"Circ Res"},{"key":"10.1016\/j.autrev.2022.103209_bb0305","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007602","article-title":"TGF-\u03b2 inhibitor therapy decreases fibrosis and stimulates cardiac improvement in a pre-clinical study of chronic Chagas\u2019 heart disease","volume":"13","author":"Ferreira","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.autrev.2022.103209_bb0310","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.2174\/138955707782331768","article-title":"Targeting of Th1-associated chemokine receptors CXCR3 and CCR5 as therapeutic strategy for inflammatory diseases","volume":"7","author":"Turner","year":"2007","journal-title":"Mini-Rev Med Chem"},{"key":"10.1016\/j.autrev.2022.103209_bb0315","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.3389\/fimmu.2017.01981","article-title":"The expanding therapeutic perspective of CCR5 blockade","volume":"8","author":"Vangelista","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2022.103209_bb0320","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/ar3685","article-title":"Maraviroc, a chemokine receptor-5 antagonist, fails to demonstrate efficacy in the treatment of patients with rheumatoid arthritis in a randomized, double-blind placebo-controlled trial","volume":"14","author":"Fleishaker","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2022.103209_bb0325","doi-asserted-by":"crossref","first-page":"S641","DOI":"10.1093\/ecco-jcc\/jjx145","article-title":"Chemokines and chemokine receptors as therapeutic targets in inflammatory bowel disease; pitfalls and promise","volume":"12","author":"Trivedi","year":"2018","journal-title":"J Crohn's Colitis"},{"key":"10.1016\/j.autrev.2022.103209_bb0330","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1002\/art.34330","article-title":"A phase II, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of MDX-1100, a fully human anti-CXCL10 monoclonal antibody, in combination with methotrexate in patients with rheumatoid arthritis","volume":"64","author":"Yellin","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2022.103209_bb0335","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1111\/trf.14841","article-title":"Systematic review of rituximab for autoimmune diseases: a potential alternative to intravenous immune globulin","volume":"58","author":"MacIsaac","year":"2018","journal-title":"Transfusion"},{"key":"10.1016\/j.autrev.2022.103209_bb0340","first-page":"222","volume":"62","author":"Merrill","year":"2010","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2022.103209_bb0345","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/art.34359","article-title":"Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: the lupus nephritis assessment with rituximab study","volume":"64","author":"Rovin","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2022.103209_bb0350","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1056\/NEJM196409242711301","article-title":"Presence of bound immunoglobulins and complement in the myocardium in acute rheumatic fever: association with cardiac failure","volume":"271","author":"Kaplan","year":"1964","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2022.103209_bb0355","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/trstmh\/trz014","article-title":"Neglecting the neglected: the objective evidence of underfunding in rheumatic heart disease","volume":"113","author":"Macleod","year":"2019","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.autrev.2022.103209_bb0360","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1080\/14740338.2017.1269168","article-title":"Hydroxychloroquine in systemic lupus erythematosus (SLE)","volume":"16","author":"Ponticelli","year":"2017","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.autrev.2022.103209_bb0365","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ijcard.2022.05.053","article-title":"Revisiting QT prolongation in acute rheumatic fever\u2013relevance for hydroxychloroquine treatment","volume":"362","author":"Perelini","year":"2022","journal-title":"Int J Cardiol"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997222001793?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997222001793?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:26:55Z","timestamp":1761600415000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997222001793"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":73,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S1568997222001793"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2022.103209","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytokine imbalance in acute rheumatic fever and rheumatic heart disease: Mechanisms and therapeutic implications","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2022.103209","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103209"}}